Arterial Hypertension
To control high blood pressure.
Irbesartan
Vascutan contains irbesartan, an angiotensin II receptor antagonist, available as tablets for oral administration. It is indicated for the treatment of essential hypertension in adults and for the treatment of renal disease in adults with hypertension and type 2 diabetes mellitus as part of an antihypertensive treatment regimen.
Vascutan is indicated for the treatment of arterial hypertension in adults and may be used as part of a combination treatment when other medications are not sufficient. It is suitable for treatment in the following conditions:
To control high blood pressure.
Treatment of renal disease in adults with hypertension and type 2 diabetes mellitus.
Provides effective blood pressure control over 24 hours with once-daily dosing.
Irbesartan is an angiotensin II receptor antagonist, effective in relaxing the blood vessels and lowering blood pressure.
It not only controls blood pressure but also offers renal protection in patients with type 2 diabetes.
How Vascutan works
Vascutan®IrbesartanVascutan contains irbesartan, an angiotensin II receptor antagonist, available as tablets for oral administration. It is indicated for the treatment of essential hypertension in adults and for the treatment of renal disease in adults with hypertension and type 2 diabetes mellitus as part of an antihypertensive treatment regimen.
Vascutan is indicated for the treatment of arterial hypertension in adults and may be used as part of a combination treatment when other medications are not sufficient. It is suitable for arterial hypertension (to control high blood pressure), renal disease in type 2 diabetes (treatment of renal disease in adults with hypertension and type 2 diabetes mellitus) and 24-hour blood pressure control (effective blood pressure control over 24 hours with once-daily dosing).
Irbesartan is an angiotensin II receptor antagonist, effective in relaxing the blood vessels and lowering blood pressure. It not only controls blood pressure but also offers renal protection in patients with type 2 diabetes.
The dose should be adjusted individually according to the severity of hypertension and the patient’s response. Typical starting dose: 150 mg once daily, with adjustments up to 300 mg according to the patient’s response. Can be administered with or without food.
The use of Irbesartan in Vascutan can significantly reduce blood pressure without causing an increase in heart rate. Facilitates the long-term management of hypertension with a low side-effect profile.
Evaluate blood pressure and renal function before starting treatment. Adjust the dose based on the patient’s blood pressure response. Monitor renal function regularly, especially in patients with cardiorenal diseases.
Monitor blood pressure regularly to ensure the effectiveness of the treatment. Use with caution in patients with fluid volume or salt disturbances. Contraindicated in patients with known hypersensitivity to irbesartan or with bilateral renal artery stenosis.
Vascutan contains irbesartan 300 mg, oral, and comes in a box of 30 or 100 tablets, following the United States Pharmacopeia standard.
Vascutan is manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality. Crassula Pharma certifies that all its products are manufactured in accordance with GMP parameters.
Manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality.
Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.